Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1996 1
1997 1
2001 1
2002 2
2003 1
2004 2
2005 1
2008 2
2009 1
2010 2
2011 2
2012 2
2015 1
2016 4
2018 1
2019 1
2022 1
2023 1
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean iloprost sraynaud digital ischemia (61 results)?
Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options.
Linnemann B, Erbe M. Linnemann B, et al. Vasa. 2016;45(3):201-12. doi: 10.1024/0301-1526/a000526. Vasa. 2016. PMID: 27129065 Review.
The primary goal of therapy is to reduce the frequency and intensity of Raynaud's attacks and to minimize the related morbidity rather than to cure the underlying condition. Treatment strategies depend on whether Raynaud's phenomenon (RP) is primary or …
The primary goal of therapy is to reduce the frequency and intensity of Raynaud's attacks and to minimize the related morbidit …
Iloprost infusion through elastomeric pump in the treatment of Raynaud's phenomenon and digital ulcers.
Fartura Braga Temido MH, Gomes M, Parente F, Santos L. Fartura Braga Temido MH, et al. J Scleroderma Relat Disord. 2019 Feb;4(1):NP1-NP4. doi: 10.1177/2397198318765596. Epub 2018 Apr 10. J Scleroderma Relat Disord. 2019. PMID: 35382145 Free PMC article.
Raynaud's phenomenon and digital ulcers are the main clinical features of vascular involvement. Treatment with iloprost is recommended to reduce the frequency and severity of Raynaud's phenomenon attacks and to heal active digital …
Raynaud's phenomenon and digital ulcers are the main clinical features of vascular involvement. Treatment with ilopr …
Raynaud's Syndrome: a neglected disease.
Poredos P, Poredos P. Poredos P, et al. Int Angiol. 2016 Apr;35(2):117-21. Epub 2015 Feb 12. Int Angiol. 2016. PMID: 25673314 Review.
Raynaud's Syndrome is a frequent manifestation of digital ischemia which occurs or is aggravated upon exposure to cold temperatures or emotional distress. ...Most of these drugs are effective in less than 50% of treated patients and do not completely a …
Raynaud's Syndrome is a frequent manifestation of digital ischemia which occurs or is aggravated upon exposure t …
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP. Wigley FM, et al. J Rheumatol. 1992 Sep;19(9):1407-14. J Rheumatol. 1992. PMID: 1279170 Clinical Trial.
OBJECTIVE: We conducted this study to assess the clinical usefulness and physiologic effects of intravenous iloprost in patients with Raynaud's phenomenon secondary to systemic sclerosis. METHODS: Thirty-five patients with Raynaud's phenomenon s …
OBJECTIVE: We conducted this study to assess the clinical usefulness and physiologic effects of intravenous iloprost in patients with …
[Paroxysmal vascular acrosyndromes: Practical approach to diagnosis and management].
Senet P. Senet P. Rev Med Interne. 2022 Oct;43(10):596-602. doi: 10.1016/j.revmed.2022.03.338. Epub 2022 Jul 11. Rev Med Interne. 2022. PMID: 35835622 French.
Paroxysmal vascular acrosyndromes are related to a peripheral vasomotor disorder and presented as paroxysmal color changes of the fingers. They include primary Raynaud's phenomenon (RP), which is the most common, secondary RP and erythermalgia. They are to be distin …
Paroxysmal vascular acrosyndromes are related to a peripheral vasomotor disorder and presented as paroxysmal color changes of the fingers. T …
Combined Thenar and Hypothenar Hammer Syndromes and Raynaud's Phenomenon Successfully Treated with Iloprost.
Ciapetti A, Carotti M, Di Carlo M, Salaffi F. Ciapetti A, et al. Case Rep Rheumatol. 2016;2016:4824929. doi: 10.1155/2016/4824929. Epub 2016 Mar 22. Case Rep Rheumatol. 2016. PMID: 27092287 Free PMC article.
The symptoms are related to the mechanism of the trauma and a Raynaud's phenomenon can be predominant for a long time. The angiography is the "gold standard" imaging technique which allows to confirm the diagnosis. ...The authors present a case of a 53-year-old man, …
The symptoms are related to the mechanism of the trauma and a Raynaud's phenomenon can be predominant for a long time. The ang …
[Iloprost for severe Raynaud's phenomenon and ischaemic ulcers related with systemic diseases].
García Hernández FJ, Ocaña Medina C, Mateos Romero L, Molinillo López J, Arias Zambrano A, González León R, Sánchez Román J. García Hernández FJ, et al. Med Clin (Barc). 2004 Apr 10;122(13):501-4. doi: 10.1016/s0025-7753(04)74287-6. Med Clin (Barc). 2004. PMID: 15104947 Clinical Trial. Spanish.
BACKGROUND AND OBJECTIVE: To evaluate the long term efficacy of treatment with intravenous iloprost for severe Raynaud's phenomenon (RP) and ischemic leg ulcers in patients with autoimmune systemic diseases. ...Side effects were seen in all cases but always d …
BACKGROUND AND OBJECTIVE: To evaluate the long term efficacy of treatment with intravenous iloprost for severe Raynaud's …
Treatment of ischaemic digital ulcers and prevention of gangrene with intravenous iloprost in systemic sclerosis.
Zachariae H, Halkier-Sørensen L, Bjerring P, Heickendorff L. Zachariae H, et al. Acta Derm Venereol. 1996 May;76(3):236-8. doi: 10.2340/0001555576236238. Acta Derm Venereol. 1996. PMID: 8800308 Free article. Clinical Trial.
One patient with severe Raynaud's phenomenon discontinued the study after 3 days due to severe headache. The 2 remaining patients with Raynaud's phenomenon as an indication improved, while no improvement was recorded in a patient with vasculitis of the …
One patient with severe Raynaud's phenomenon discontinued the study after 3 days due to severe headache. The 2 remaining patie …
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis.
Thompson AE, Shea B, Welch V, Fenlon D, Pope JE. Thompson AE, et al. Arthritis Rheum. 2001 Aug;44(8):1841-7. doi: 10.1002/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8. Arthritis Rheum. 2001. PMID: 11508437
OBJECTIVE: Most patients with systemic sclerosis (SSc) have Raynaud's phenomenon (RP), which is often more severe than idiopathic RP. This study was a meta-analysis to determine the efficacy of calcium-channel blockers for the treatment of RP in SSc. The primary out …
OBJECTIVE: Most patients with systemic sclerosis (SSc) have Raynaud's phenomenon (RP), which is often more severe than idiopat …
[Current treatment of systemic sclerosis. Part II. Vascular and antifibrotic treatment].
Sicińska J, Rudnicka L. Sicińska J, et al. Pol Merkur Lekarski. 2008 Aug;25(146):196-200. Pol Merkur Lekarski. 2008. PMID: 18942347 Review. Polish.
Calcium channel blockers, ACE inhibitors, sartans, phosphodiesterase-5 inhibitors and serotonin re-uptake blockers are used for Raynaud's phenomenon. Intravenous prostanoids (alprostadil, iloprost, epoprostenol, treprostinil) and endothelin receptor antagonis …
Calcium channel blockers, ACE inhibitors, sartans, phosphodiesterase-5 inhibitors and serotonin re-uptake blockers are used for Raynaud …
25 results